CRPC: therapeutic options
Added: Friday 20 December 2013
Castration-resistant prostate cancer (CRPC) tends to have a poor prognosis. However, there has recently been an expansion in the number of different treatment options available. An article published in <cite>Touch Oncology</cite> reviews the therapies currently available. It was one of the website's most popular articles of 2013.
In order to be able to see the content from the www.medscape.com pages, please create first a free account at following link: